Yasuhiro Goto

12PUBLICATIONS
139CO-AUTHORS
Predictive and prognostic markersCancer geneticsAutoimmunityMolecular targetsCarbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 10, 2025
Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer.

Tae Hata, Tadaaki Yamada, Yasuhiro Goto

|May 19, 2025
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan.

Shiho Goda, Tadaaki Yamada, Kenji Morimoto

|Apr 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.

Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi

|Jan 03, 2025
Blood DNA virome associates with autoimmune diseases and COVID-19.

Noah Sasa, Shohei Kojima, Rie Koide

|Nov 04, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers.

Yuki Katayama, Tadaaki Yamada, Keiko Tanimura

|Sep 16, 2024
It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC.

Ken Akao, Yuko Oya, Takaya Sato

Pageof 2

Frequent Collaborators

5 joint publications

Naoki Furuya

4 joint publications

Tadaaki Yamada

4 joint publications

Koichi Takayama

3 joint publications

Kazuyoshi Imaizumi